New hope for kids with tough cancers: experimental drug CLR 131 tested

NCT ID NCT03478462

First seen Mar 22, 2026 · Last updated Jun 15, 2026 · Updated 16 times

Summary

This study tests an experimental drug, CLR 131, in children, adolescents, and young adults with certain cancers (like neuroblastoma, lymphoma, and brain tumors) that have come back or not responded to standard treatments. The main goal is to find a safe dose and see if the drug can shrink tumors. About 30 participants will receive the drug, and researchers will monitor side effects and any anti-cancer activity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Children's Hospital at Westmead

    Westmead, New South Wales, 2145, Australia

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio, 45229, United States

  • Duke University

    Chapel Hill, North Carolina, 27708, United States

  • Hospital for Sick Children

    Toronto, Ontario, M5G1X8, Canada

  • Lucile Packard Children's Hospital

    Palo Alto, California, 94304, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Texas Children's Hospital

    Houston, Texas, 77030, United States

  • University of Wisconsin Hospital and Clinics

    Madison, Wisconsin, 53792, United States

Conditions

Explore the condition pages connected to this study.